Jessica Tassan

Stock Analyst at Piper Sandler

(2.05)
# 2,911
Out of 4,883 analysts
72
Total ratings
40.35%
Success rate
-5.85%
Average return

Stocks Rated by Jessica Tassan

Hinge Health
Jun 16, 2025
Initiates: Overweight
Price Target: $41
Current: $44.61
Upside: -8.09%
Oscar Health
Jun 9, 2025
Maintains: Overweight
Price Target: $25$18
Current: $16.62
Upside: +8.30%
UnitedHealth Group
Jun 3, 2025
Maintains: Overweight
Price Target: $552$353
Current: $307.56
Upside: +14.77%
Claritev
May 29, 2025
Upgrades: Overweight
Price Target: $19$44
Current: $42.50
Upside: +3.53%
American Well
May 23, 2025
Reiterates: Neutral
Price Target: $10$8
Current: $8.59
Upside: -6.87%
Premier
May 21, 2025
Maintains: Neutral
Price Target: $19$24
Current: $21.73
Upside: +10.45%
The Cigna Group
May 5, 2025
Maintains: Overweight
Price Target: $348$374
Current: $320.39
Upside: +16.73%
CVS Health
Mar 21, 2025
Maintains: Overweight
Price Target: $72$74
Current: $66.60
Upside: +11.11%
Alignment Healthcare
Mar 4, 2025
Maintains: Overweight
Price Target: $14$21
Current: $13.61
Upside: +54.30%
Teladoc Health
Feb 27, 2025
Maintains: Overweight
Price Target: $13$12
Current: $8.35
Upside: +43.71%
Reiterates: Overweight
Price Target: $17$16
Current: $11.73
Upside: +36.40%
Maintains: Overweight
Price Target: $12$8
Current: $4.06
Upside: +97.29%
Reiterates: Overweight
Price Target: $31$33
Current: $29.08
Upside: +13.48%
Maintains: Neutral
Price Target: $270$288
Current: $243.79
Upside: +18.13%
Maintains: Neutral
Price Target: $21$23
Current: $59.31
Upside: -61.22%
Downgrades: Neutral
Price Target: $66$70
Current: $29.79
Upside: +134.98%